The Aplastic Anaemia Gene Panel investigates 46 genes associated with inherited bone marrow failure syndromes using Next-Generation Sequencing (NGS), helping clinicians identify the underlying genetic causes of aplastic anaemia.
Accredited Genomics Laboratory
Peripheral Blood Sample
46-Gene Sequencing Panel
Expert Variant Interpretation
The Aplastic Anaemia Gene Panel evaluates 46 clinically relevant genes involved in bone marrow failure syndromes, DNA repair, telomere maintenance and inherited aplastic anaemia disorders.
Aplastic anaemia is a rare disorder in which the bone marrow fails to produce enough healthy blood cells. This can lead to fatigue, increased risk of infections and excessive bleeding. Identifying the underlying genetic cause can support accurate diagnosis and personalized patient management.
From a simple blood sample to an expert-reviewed clinical report, the Aplastic Anaemia Gene Panel follows a comprehensive genomic workflow to identify disease-associated genetic variants.
Peripheral blood sample collected for genetic testing.
High-quality genomic DNA is extracted from the blood sample.
Advanced NGS technology analyzes all 46 genes in the panel.
Clinical experts interpret disease-associated genetic variants.
Comprehensive genetic report delivered within 19 Working Days.
Improve the evaluation of aplastic anaemia through comprehensive genetic analysis. Generate actionable genomic insights that enhance diagnostic confidence and support better clinical decision-making for personalized patient care.